Baxter International Inc.

BAX · NYSE · S&P 500 · Medical - Instruments & Supplies

$24.15

−1.31 · −5.16% today

Market open · updated 12:18:50 PM ET

Oct 29, 2026 +4.20%

High
$26.53 5:15 AM
Low
$26.01 4:45 AM

Against the S&P 500 Price change through Oct 28, 2026

This year

BAX+33.23%

S&P 500+13.26%

1 year

BAX+11.37%

S&P 500+12.41%

3 years

BAX−20.83%

S&P 500+88.06%

5 years

BAX−67.61%

S&P 500+68.51%

Key numbers

Previous close
$25.46
Open
$26.00
Day's range
$23.50 – $26.10
52-week range
$15.73 – $30.00
Volume
7.7 million
Average volume
6.4 million
Market value
$12.5 billion
Earnings per share
-$2.06last 12 months
Beta
0.65moves less than the market
Dividend
$0.04 a year · 0.16%
50-day average
$24.71
200-day average
$21.30
Next earnings

Thursday, Oct 29, 2026, before the open.

Analyst price targets and the full financials are in the terminal.

Who Baxter International buys from and competes with From our value chain

Baxter International in the news

  • HeadlineWill Baxter's Q3 Earnings Show Progress Despite Cost Pressures?Zacks Investment Research · October 26, 2026 at 12:26 PM ET
  • Week aheadWeek Ahead: Fed Decision, GDP, PCE Inflation and Peak Earnings WeekWiseView Research desk · October 25, 2026
  • CongressRo Khanna bought $1,001 - $15,000 of BAXHouse filing · disclosed Jun 11, 2026
  • CongressMichael McCaul bought $15,001 - $50,000 of BAXHouse filing · disclosed Apr 10, 2026
  • CongressMichael McCaul bought $50,001 - $100,000 of BAXHouse filing · disclosed Feb 12, 2026
  • CongressLisa McClain sold $1,001 - $15,000 of BAXHouse filing · disclosed Nov 24, 2025
  • CongressLisa McClain bought $1,001 - $15,000 of BAXHouse filing · disclosed Nov 24, 2025
  • CongressLisa McClain sold $1,001 - $15,000 of BAXHouse filing · disclosed Nov 24, 2025

Earnings

Next report: Thursday, Oct 29, 2026, before the open.

Congress trades in BAX

6 purchases and 2 sales in the latest 8 filings.

MemberTradeAmountTradedDisclosed
Ro KhannaHouse · D-CaliforniaPurchase$1,001 - $15,000May 1, 2026Jun 11, 2026
Michael McCaulHouse · R-TexasPurchase$15,001 - $50,000Mar 23, 2026Apr 10, 2026
Michael McCaulHouse · R-TexasPurchase$50,001 - $100,000Jan 13, 2026Feb 12, 2026
Lisa McClainHouse · R-MichiganSale$1,001 - $15,000Oct 31, 2025Nov 24, 2025
Lisa McClainHouse · R-MichiganPurchase$1,001 - $15,000Oct 30, 2025Nov 24, 2025
Lisa McClainHouse · R-MichiganSale$1,001 - $15,000Oct 30, 2025Nov 24, 2025
Lisa McClainHouse · R-MichiganPurchase$1,001 - $15,000Sep 25, 2025Oct 22, 2025
Ro KhannaHouse · D-CaliforniaPurchase$1,001 - $15,000Sep 29, 2025Oct 3, 2025

Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.

About Baxter International

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
37,500
Headquarters
Deerfield, Illinois
Website
baxter.com
Listed
Oct 27, 1981

More medical - instruments & supplies stocks

The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.

Follow BAX in the terminal.

Membership details

14-day free trial · no card needed · nothing to cancel.

Then $83/mo billed annually — $997 once a year.

WiseView provides market data and research tools for educational purposes. Nothing here is investment advice. Past performance does not predict future results.